Covered recipient · General Payments record
GABRIELLE ALYSSA BORBOA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2024
$589.20
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $589.20 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| OPKO Pharmaceuticals, LLC | $139.17 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $124.99 | 1 |
| Acerta Pharma LLC | $109.01 | 1 |
| Amgen Inc. | $86.10 | 1 |
| AKEBIA THERAPEUTICS INC | $51.66 | 1 |
| Lilly USA, LLC | $33.38 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $28.36 | 1 |
| ANI Pharmaceuticals, Inc. | $16.53 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $589.20 | 9 |
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AKEBIA THERAPEUTICS INC | $51.66 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145830896 | CMS |
| Amgen Inc. | $86.10 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117510939 | CMS |
| ANI Pharmaceuticals, Inc. | $16.53 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091142592 | CMS |
| AstraZeneca Pharmaceuticals LP | $109.01 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104568398 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $28.36 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086360198 | CMS |
| Lilly USA, LLC | $33.38 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135660179 | CMS |
| Novartis Pharmaceuticals Corporation | $124.99 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086778131 | CMS |
| OPKO Pharmaceuticals, LLC | $14.18 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112851552 | CMS |
| OPKO Pharmaceuticals, LLC | $124.99 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112851554 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.